Related Topics News -

     
 Title only   |   Print 
     
恆瑞醫藥碘佛醇注射液新增進入國家基本藥物目錄

2026-07-13T  
《大行》瑞銀:恆瑞減重藥HRS-7535臨床數據正面 估值吸引重申「買入」

2026-07-09T  
恆瑞醫藥SHR-4685注射液將於近期進行臨床試驗

2026-07-08T  
《信而有證》半導體股獲熱炒 華虹彈一成半兼破頂 創新藥板塊再上揚 阿里失守「紅底」傳擬出售遊戲業務

2026-06-24T  
藥明生物藥明康德升近6%及9% 花旗:中國醫療保健板塊估值吸引呈良好入市點

2026-06-24T  
《信而有證》內地支持外資參與金融及醫藥等產業發展 中資金融、生物醫藥板塊逆市拉升

2026-06-23T  
《輪動華泰》美暫緩對伊朗石油制裁 資金續撈恆指好倉

2026-06-23T  
恆瑞醫藥治療前列腺癌注射液臨床獲批

2026-06-17T  
《大行》摩通升恆瑞醫藥評級至「增持」 目標價降至68元

2026-06-16T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.